These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 3473684)

  • 1. Continuous infusion high-dose cytosine arabinoside without anthracyclines as induction and intensification therapy in adults under age 50 with newly diagnosed acute myelogenous leukemia.
    Estey E; Keating MJ; Plunkett W; McCredie KB; Freireich EJ
    Semin Oncol; 1987 Jun; 14(2 Suppl 1):58-63. PubMed ID: 3473684
    [No Abstract]   [Full Text] [Related]  

  • 2. Amsacrine and continuous-infusion high-dose cytosine arabinoside as induction therapy for patients with newly-diagnosed acute myelogenous leukemia.
    Ghaddar HM; Pierce S; Kantarjian HM; Freireich EJ; Keating MJ; Estey EH
    Leuk Lymphoma; 1996 Jun; 22(1-2):71-6. PubMed ID: 8724530
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sequential therapy for induction and maintenance of remission in acute myeloblastic leukemia.
    Eppinger-Helft M; Pavlovsky S; Suarez A; Muriel FS; Hidalgo G; Pavlovsky A; Vilaseca G
    Cancer; 1975 Feb; 35(2):347-53. PubMed ID: 1053936
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Induction and intensive combined therapy of acute myeloid leukemia in adults].
    Kurrle E; Ehninger G; Freund M; Heil G; Hoelzer D; Link H; Mitrou PS; Ohl S; Queisser W; Schlimok G
    Onkologie; 1988 Feb; 11(1):5-9. PubMed ID: 3283626
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DNA as a carrier for anthracyclines in the treatment of acute myelocytic leukemia (AML).
    Gahrton G; Tidefelt U; Paul C; Björkholm M; Grimfors G; Hast R; Juliusson G; Järnmark M; Killander A; Kimby E
    Leukemia; 1992; 6 Suppl 2():89-91. PubMed ID: 1578953
    [No Abstract]   [Full Text] [Related]  

  • 6. Cytosine arabinoside in experimental combination therapy.
    Edelstein M; Valeriote F
    Semin Oncol; 1985 Jun; 12(2 Suppl 3):75-83. PubMed ID: 3892705
    [No Abstract]   [Full Text] [Related]  

  • 7. Pharmacologic studies of low-dose and high-dose continuous infusion cytosine arabinoside.
    Kufe DW; Spriggs DR; Griffin JD
    Semin Oncol; 1987 Jun; 14(2 Suppl 1):149-58. PubMed ID: 3473675
    [No Abstract]   [Full Text] [Related]  

  • 8. [Intensification of chemotherapy of acute myeloid leukemia in children: report on the studies of the AML-BFM 78 and AML-BFM 83 protocols].
    Creutzig U; Ritter I; Schellong G
    Gematol Transfuziol; 1991 Jan; 36(1):16-21. PubMed ID: 2065939
    [No Abstract]   [Full Text] [Related]  

  • 9. [Advances in the treatment of acute myeloid leukemia in children. Experience of the Argentinian Group of Acute Leukemia Treatment and the Latin American Group of Malignant Hemopathies Treatment 1967-1987].
    Freigeiro D; Scaglione C; Santarelli MT; Sackmann Muriel F; Jiménez E; Pavlovsky S; Bustelo P; Richard L; Kohan R; Kvicala R
    Sangre (Barc); 1989 Jun; 34(3):221-8. PubMed ID: 2669186
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early intensification and short-term maintenance chemotherapy does not prolong survival in acute myelogenous leukemia.
    Kantarjian HM; Keating MJ; Walters RS; McCredie KB; Bodey GP; Freireich EJ
    Cancer; 1986 Oct; 58(8):1603-8. PubMed ID: 3463390
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neurological complications during treatment of childhood cancer: mind Wernicke encephalopathy.
    La Spina M; Catania R; Lo Nigro L; De Grandi C; Palmucci S; Di Cataldo A
    Pediatr Hematol Oncol; 2010 May; 27(4):320-3. PubMed ID: 20426524
    [No Abstract]   [Full Text] [Related]  

  • 12. [A case of refractory acute myeloblastic leukemia who achieved partial remission by high dose cytosine arabinoside].
    Okamoto S; Ogata H; Yoshida T; Oheda Y; Murase T; Toyama K
    Rinsho Ketsueki; 1984 May; 25(5):719-23. PubMed ID: 6590900
    [No Abstract]   [Full Text] [Related]  

  • 13. [Investigations in the use of mogramostime (GM-CSF) in patients with acute leukemia].
    Paśnicki M
    Wiad Lek; 1995; 48(1-12):194-7. PubMed ID: 9638239
    [No Abstract]   [Full Text] [Related]  

  • 14. Intensive treatment of acute leukemia in adults 70 years of age and older.
    Walters RS; Kantarjian HM; Keating MJ; Estey EH; McCredie KB; Freireich EJ
    Cancer; 1987 Jul; 60(2):149-55. PubMed ID: 3474052
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acute myeloid leukemia in adults: experience at AIIMS.
    Raina V; Kochupillai V
    J Assoc Physicians India; 1983 Aug; 31(8):511-4. PubMed ID: 6581155
    [No Abstract]   [Full Text] [Related]  

  • 16. Sequential vincristine, arabinosylcytosine and daunomycin induction therapy in adult acute leukemia.
    Riccardi A; Invernizzi R; Girino M; Cassano E; Giordano M; Ucci G; Danova M; Montecucco C; Bobbio-Pallavicini E; Ascari E
    Haematologica; 1986; 71(2):129-33. PubMed ID: 3087833
    [No Abstract]   [Full Text] [Related]  

  • 17. [Intensive induction chemotherapy of adult acute myelogenous leukemia by continuing daunorubicin, behenoyl-cytosine arabinoside, 6-mercaptopurine and prednisolone until marrow aplasia].
    Taguchi H; Kubonishi I; Takehara N; Uemura Y; Iwahara Y; Eguchi T; Miyagi T; Sugito S; Muneishi H; Tanaka Y
    Gan To Kagaku Ryoho; 1992 Aug; 19(9):1309-14. PubMed ID: 1503485
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Translocation (9;17) a novel translocation in acute myeloid leukaemia.
    Brown SA; Czepulkowski B; Ireland R
    Leuk Res; 1996; 20(11-12):987-8. PubMed ID: 9009258
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fractionated anthracycline therapy in acute myeloblastic leukaemia in adults.
    Donohue SM; Boughton BJ
    Cancer Chemother Pharmacol; 1989; 23(6):401-2. PubMed ID: 2713963
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interim comparison of a continuous infusion versus a short daily infusion of cytarabine given in combination with cladribine for pediatric acute myeloid leukemia.
    Crews KR; Gandhi V; Srivastava DK; Razzouk BI; Tong X; Behm FG; Plunkett W; Raimondi SC; Pui CH; Rubnitz JE; Stewart CF; Ribeiro RC
    J Clin Oncol; 2002 Oct; 20(20):4217-24. PubMed ID: 12377965
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.